Drug profile · INN
indometacin
ARTHREXIN
indometacin (ARTHREXIN) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — indometacin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
indometacin (ARTHREXIN) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN indometacin
Brand ARTHREXIN
Mechanism Cyclooxygenase inhibitor
Target Cyclooxygenase
Originator Alphapharm Pty Ltd
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is indometacin?
indometacin (ARTHREXIN) is a cyclooxygenase inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for indometacin?
ARTHREXIN is a marketed brand name for indometacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.